Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses

[1]  Ryoichi Arai,et al.  Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies , 2014, Human molecular genetics.

[2]  H. Okano,et al.  Modeling human neurological disorders with induced pluripotent stem cells , 2014, Journal of neurochemistry.

[3]  Hideyuki Okano,et al.  iPS cell technologies: significance and applications to CNS regeneration and disease , 2014, Molecular Brain.

[4]  G. Kirov,et al.  Analysis of copy number variations at 15 schizophrenia-associated loci , 2014, The British journal of psychiatry : the journal of mental science.

[5]  K. Kasai,et al.  Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia , 2014, Neuron.

[6]  G. Remington,et al.  Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls , 2013, Journal of clinical psychopharmacology.

[7]  H. Okano,et al.  Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: Utility and limitation of the surrogate tissues in research for brain disorders , 2013, Neuroscience Research.

[8]  Marenao Tanaka,et al.  Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population , 2013, PloS one.

[9]  A. Duttaroy,et al.  Fatty acid-induced angiogenesis in first trimester placental trophoblast cells: possible roles of cellular fatty acid-binding proteins. , 2013, Life sciences.

[10]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[11]  J. Newcomer,et al.  Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophrenia. , 2013, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[12]  G. Hotamisligil,et al.  Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. , 2013, Cell metabolism.

[13]  D. Geschwind,et al.  Genes for endosomal NHE6 and NHE9 are misregulated in autism brains , 2013, Molecular Psychiatry.

[14]  P. Mistriotis,et al.  Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicine. , 2013, Tissue engineering. Part B, Reviews.

[15]  H. Okano,et al.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.

[16]  H. Okano,et al.  Neural Stem Cells Directly Differentiated from Partially Reprogrammed Fibroblasts Rapidly Acquire Gliogenic Competency , 2012, Stem cells.

[17]  Olga Peñagarikano,et al.  What does CNTNAP2 reveal about autism spectrum disorder? , 2012, Trends in molecular medicine.

[18]  H. Okano,et al.  Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.

[19]  H. Okano,et al.  Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.

[20]  S. Ruhrmann,et al.  The near Babylonian speech confusion in early detection of psychosis. , 2011, Schizophrenia bulletin.

[21]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[22]  K. Hashimoto,et al.  Association analyses between brain‐expressed fatty‐acid binding protein (FABP) genes and schizophrenia and bipolar disorder , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  Y. Iwayama,et al.  Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects , 2010, Journal of Human Genetics.

[24]  N. Andreasen,et al.  Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs , 2010, Biological Psychiatry.

[25]  K. Inokuchi,et al.  Arachidonic Acid Drives Postnatal Neurogenesis and Elicits a Beneficial Effect on Prepulse Inhibition, a Biological Trait of Psychiatric Illnesses , 2009, PloS one.

[26]  T. Furuichi,et al.  Developmentally Regulated Ca2+-Dependent Activator Protein for Secretion 2 (CAPS2) is Involved in BDNF Secretion and is Associated with Autism Susceptibility , 2009, The Cerebellum.

[27]  David A Lewis,et al.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. , 2008, The American journal of psychiatry.

[28]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[29]  K. Hashimoto,et al.  Fabp7 Maps to a Quantitative Trait Locus for a Schizophrenia Endophenotype , 2007, PLoS biology.

[30]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[31]  P. Schirmacher,et al.  K25 (K25irs1), K26 (K25irs2), K27 (K25irs3), and K28 (K25irs4) represent the type I inner root sheath keratins of the human hair follicle. , 2006, The Journal of investigative dermatology.

[32]  E. Birgitte Lane,et al.  New consensus nomenclature for mammalian keratins , 2006, The Journal of cell biology.

[33]  F. Spener,et al.  Fatty acid-binding proteins--insights from genetic manipulations. , 2004, Progress in lipid research.

[34]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[35]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[36]  Jeffrey B. Boord,et al.  Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis , 2002, Current opinion in lipidology.

[37]  F. Benes,et al.  GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder , 2001, Neuropsychopharmacology.

[38]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[40]  Yasuomi Ouchi,et al.  Microglial activation in young adults with autism spectrum disorder. , 2013, JAMA psychiatry.

[41]  M. Fasshauer,et al.  Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? , 2012, Diabetologia.

[42]  T. Yoshikawa,et al.  Role of polyunsaturated fatty acids and fatty acid binding protein in the pathogenesis of schizophrenia. , 2011, Current pharmaceutical design.

[43]  治徳 大介.  Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample , 2011 .